Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Active Pharmaceutical Ingredients - Global Market Outlook (2016-2022) - Research and Markets

Research and Markets
Posted on: 31 Jul 17

The "Active Pharmaceutical Ingredients - Global Market Outlook (2016-2022)" report has been added to Research and Markets' offering.

The Global Active Pharmaceutical Ingredients market is expected to reach $198.8 billion by 2022 with a CAGR of 6.4%.

Patent expiration of prominent drugs, government initiatives, regional penetration and increasing aged population are some of the factors that are driving the market growth.

Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.

Generic/Non-Branded segment witnessed the largest market share during the forecast period due to rising healthcare costs, government prominence on generics for dropping healthcare costs, and decreasing pipelines of global pharmaceutical products.

Asia Pacific is expected to be highest market share during the forecast period due to low operation costs and high investments in medical research.

Types of API Covered:

Synthetic chemical API

  • Branded/ Innovative
  • Generic/Non- Branded

Biological API

  • Biotech
  • Biosimilar

High potency active pharmaceutical ingredients(HPAPI)

Manufacturing Types Covered:

  • Captive (or in-house) manufacturing
  • Contract manufacturing

Therapeutic Applications Covered:

  • Anti-Infectives
  • Cardiovascular and hematopoietic system
  • CNS and Neurological Disorders
  • Diabetes
  • Endocrinology
  • Gastrointestinal disorder
  • Hormonal-related disorder
  • Metabolic disorder
  • Musculoskeletal disorder
  • Nephrology
  • Oncology
  • Ophthalmology
  • Orthopedic Disorders
  • Pulmonology

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Active Pharmaceutical Ingredients Market, By Types of API

6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturing

7 Global Active Pharmaceutical Ingredients Market, By Therapeutic Application

8 Global Active Pharmaceutical Ingredients Market, By Geography

9 Key Developments

10 Company Profiling

  • Aurobindo Pharma Ltd.
  • Bayer Healthcare (Germany)
  • Bioniche Animal Health (Canada)
  • Boehringer Ingelheim (Germany)
  • Ceva Animal Health, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Elanco Animal Health (U.S.)
  • Heska Co. (U.S.)
  • Merck Animal Health (U.S.)
  • Merial Inc. (Sanofi) (France)
  • Novartis International AG
  • Pfizer, Inc
  • Ranbaxy Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited
  • Virbac
  • Zoetis (U.S.)

For more information about this report visit https://www.researchandmarkets.com/research/lt5lk9/active

View source version on businesswire.com: http://www.businesswire.com/news/home/20170731005911/en/

Business Wire
www.businesswire.com

Last updated on: 31/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.